title: Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab.
abstract: The treatment of ulcerative colitis has changed over the last decade, with the introduction of biological drugs. This article reviews the currently available therapies for ulcerative colitis and the specific use of these therapies in the management of patients in different settings, particularly the difficult-to-treat patients. The focus of this review is on adalimumab, which has recently obtained approval by the European Medicines Agency and the US Food and Drug Administration, for use in treating adult patients with moderate-to-severe, active ulcerative colitis, who are refractory, intolerant, or who have contraindications to conventional therapy, including corticosteroids and thiopurines. Since the results emerging from the pivotal trials have been subject to some debate, the aim of this review was to summarize all available data on the use of adalimumab in ulcerative colitis, focusing also on a retrospective series of real-life experiences. Taken together, the current evidence indicates that adalimumab is effective for the treatment of patients with different types of ulcerative colitis, including biologically naïve and difficult-to-treat patients.
authors: IBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy. alearmuzzi@yahoo.com
authors: Alessandro
authors: A
authors: Armuzzi
authors: Daniela
authors: D
authors: Pugliese
authors: Olga Maria
authors: OM
authors: Nardone
authors: Luisa
authors: L
authors: Guidi
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab
keywords: randomized controlled trials; real-life experiences
references: Am J Gastroenterol. 2011 Apr;106(4):601-16
references: 21407188
references: Gut. 2011 Jun;60(6):780-7
references: 21209123
references: Gastroenterology. 2012 Feb;142(2):257-65.e1-3
references: 22062358
references: Inflamm Bowel Dis. 2013 Jul;19(8):1700-9
references: 23665965
references: Gastroenterology. 2007 Jan;132(1):52-65
references: 17241859
references: J Crohns Colitis. 2013 Mar;7(2):150-3
references: 22520592
references: J Crohns Colitis. 2012 Dec;6(10):991-1030
references: 23040451
references: Lancet. 2012 Dec 1;380(9857):1909-15
references: 23063316
references: Aliment Pharmacol Ther. 2008 Sep 15;28(6):674-88
references: 18532990
references: Gastroenterology. 2006 Feb;130(2):323-33; quiz 591
references: 16472588
references: Gastroenterology. 2009 Nov;137(5):1628-40
references: 19664627
references: Aliment Pharmacol Ther. 2010 Aug;32(4):522-8
references: 20500733
references: J Crohns Colitis. 2013 Oct;7(9):717-22
references: 23142005
references: Inflamm Bowel Dis. 2013 Apr;19(5):1065-72
references: 23448790
references: Ann Rheum Dis. 2009 Dec;68(12):1863-9
references: 19147611
references: J Crohns Colitis. 2012 Dec;6(10):965-90
references: 23040452
references: N Engl J Med. 1990 Nov 1;323(18):1228-33
references: 2215606
references: Gut. 2006 Jan;55(1):47-53
references: 15972298
references: Gut. 2009 Jul;58(7):940-8
references: 19201775
references: Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A
references: 16151544
references: Aliment Pharmacol Ther. 2008 Oct 15;28(8):966-72
references: 18652603
references: Gastroenterology. 2007 Feb;132(2):763-86
references: 17258735
references: Scand J Gastroenterol. 2009;44(4):431-40
references: 19101844
references: Ann Intern Med. 2007 Jun 19;146(12):829-38
references: 17470824
references: Aliment Pharmacol Ther. 2013 Jan;37(2):204-13
references: 23173821
references: Inflamm Bowel Dis. 2009 Sep;15(9):1302-7
references: 19408340
references: N Engl J Med. 2005 Dec 8;353(23):2462-76
references: 16339095
references: Clin Gastroenterol Hepatol. 2006 Jun;4(6):760-5
references: 16716758
references: Dig Liver Dis. 2013 Sep;45(9):738-43
references: 23683530
references: Aliment Pharmacol Ther. 2010 Jun;31(12):1296-309
references: 20298496
references: Aliment Pharmacol Ther. 2011 Feb;33(3):340-8
references: 21133961